Ownership and insider activity for BGM Group Ltd. (BGM): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Operating from Chengdu, People's Republic of China, BGM Group Ltd. engages in the manufacturing and supply of active pharmaceutical ingredients (APIs), traditional Chinese medicine (TCM) derivatives, and various other related products across China.
Price
| Price | $9.35 |
| Market Cap | $119M |
| Exchange | NASDAQ |
| Country | CN |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-03-31 | ren yuehua | |||
| 2026-03-31 | ZHAI Yaxuan | |||
| 2026-03-31 | XU WAIHUA | |||
| 2026-04-28 | Lou Zefei | |||
| 2026-04-13 | ZHANG LIN (Henry) |
Balance Sheet (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.4M | $5.3M | $4.6M | $11.9M | $10.5M | $14.3M | $7.5M | $9.8M | $9.8M |
| Short-term Investments | 0 | $14,578 | 0 | 0 | 0 | 0 | $14.9M | $8.3M | $994,895 |
| Receivables | $1.0M | $5.3M | $6.1M | $12.6M | $13.5M | $4.9M | $6.4M | $5.8M | $17.0M |
| Inventory | $12.9M | $9.6M | $12.5M | $12.0M | $12.5M | $8.9M | $5.0M | $5.0M | $23.7M |
| Total Current Assets | $22.0M | $22.2M | $25.0M | $37.5M | $40.4M | $30.0M | $34.5M | $29.8M | $51.5M |
| Property, Plant & Equipment | $8.8M | $8.5M | $7.7M | $7.7M | $11.5M | $12.3M | $12.7M | $14.9M | $15.1M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $350.8M |
| Intangible Assets | $2.1M | $2.0M | $1.8M | $1.9M | $1.9M | $1.7M | $3.4M | $4.5M | $4.5M |
| Total Assets | $33.4M | $33.3M | $35.3M | $48.1M | $75.4M | $64.5M | $51.3M | $53.0M | $433.8M |
| Accounts Payable | $4.7M | $3.8M | $3.6M | $4.4M | $6.6M | $5.3M | $3.6M | $4.1M | $6.6M |
| Short-term Debt | $6.9M | $4.2M | $4.9M | $7.3M | $7.9M | $1.7M | $479,715 | 0 | $1.9M |
| Total Current Liabilities | $18.0M | $14.3M | $11.7M | $18.4M | $18.2M | $9.2M | $6.7M | $8.8M | $41.6M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | $19.7M | $15.6M | $12.6M | $19.3M | $18.7M | $9.6M | $6.9M | $8.9M | $41.7M |
| Retained Earnings | $3.1M | $2.9M | $7.6M | $12.2M | $14.7M | $15.5M | $5.9M | $4.3M | -$15.8M |
| Total Equity | $11.2M | $15.3M | $19.9M | $26.1M | $54.9M | $53.1M | $42.8M | $42.7M | $390.9M |
| Total Debt | $6.9M | $4.2M | $4.9M | $7.6M | $8.0M | $1.8M | $577,850 | 0 | $1.9M |
| Net Debt | $1.6M | -$1.1M | $308,688 | -$4.3M | -$2.4M | -$12.6M | -$21.8M | -$18.1M | -$8.9M |
| Working Capital | $4.0M | $7.9M | $13.3M | $19.1M | $22.2M | $20.9M | $27.9M | $21.0M | $9.9M |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 1.25 |
Profitability
| Return on Equity | -5.37% |
| Return on Invested Capital | -2.80% |
| Return on Assets | -4.85% |
| Gross Margin | 12.81% |
| Operating Margin | -23.42% |
| Net Margin | -44.22% |
Related companies: ANIP · AVDL · CLOV · EWTX · GPCR · MESO · PAHC
Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic
More sections of BGM: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks